Company / Net Income
BioAge Labs, Inc. Net Income History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$80.6M
FY2025
5-year range
-$80.6M / -$63.9M
FY2023-FY2025
Trend
-13.4%
vs FY2024
Sector context
#99 of 216
Health Care
What the data says
At -$81M, BioAge Labs, Inc.'s net income ranks #99 of 216 in the Health Care sector. Declined from -$64M to -$81M over the past 2 years.
Based on SEC 10-K filings.
-$81M in FY2025.
Declined from -$64M to -$81M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#99 of 216 in Health CareTop 46% of 216This company -$80.6M Sector average $454.3M
▼
-117.7% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 13.4% year-over-year.
- Ranks #99 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$80.6M | -13.4% |
| FY2024 | -$71.1M | -11.4% |
| FY2023 | -$63.9M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026